Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Forxiga Approval Should Be Boon For AstraZeneca And Bristol-Myers Squibb

[at Seeking Alpha] – Both AstraZeneca PLC ( AZN ) and the Bristol-Myers Squibb Co. ( BMY ) are anticipated beneficiaries of the U.S. Food and Drug Administration announcement Wednesday that it has . . . → Read More: Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Forxiga Approval Should Be Boon For AstraZeneca And Bristol-Myers Squibb